-
Biomed Industries Presents Four Breakthrough Studies on Alzheimer’s, Rett Syndrome, and Obesity Therapies at AAIC 2025
04 Aug 2025 10:00 GMT
… — including aducanumab, lecanemab, donanemab, gantenerumab, bapineuzumab, crenezumab, and solanezumab — challenges this …
-
Epitope Sequence and Modification Fingerprints of Anti-Aβ Antibodies
09 May 2025 22:25 GMT
… towards aggregated Aβ [40, 41]. Bapineuzumab, the humanized form of the … of 3D6 (murine precursor of Bapineuzumab) and expanded the binding interface …
-
Elk Grove hospital hosts trials on potential new Alzheimer's treatments
16 Feb 2025 13:23 GMT
… conduct trials for the drug bapineuzumab, which wasn’t approved but …
-
Monoclonal antibodies: are they the key to treating Alzheimer’s disease?
10 Feb 2025 14:47 GMT
… treating Alzheimer’s disease was bapineuzumab, a humanized variant of anti …
-
What drugmakers did not tell volunteers in Alzheimer’s trials
24 Oct 2024 00:41 GMT
… failure involved a drug called bapineuzumab, known as bapi. Wall Street … ’s research “may hinge on bapineuzumab’s outcome.” Those hopes dimmed …
-
Prevention and Treatment Strategies for Alzheimer’s Disease: Focusing on Microglia and Astrocytes in Neuroinflammation
12 Oct 2024 13:53 GMT
… for oligomers, while others like bapineuzumab and solanezumab are intended for … aseptic meningitis.23,24 Both bapineuzumab and solanezumab encountered challenges in …
-
Could Kisunla approval mark a turning point in Alzheimer’s treatment?
05 Jul 2024 17:47 GMT
… trial failures, including those of bapineuzumab, solanezumab, and santenerumab, which all …
-
Review of Pharmacotherapeutic Targets in Alzheimer’s Disease and Its Management Using Traditional Medicinal Plants
18 May 2024 13:43 GMT
… , solanezumab from Eli Lilly, and bapineuzumab from Pfizer.113
Function of …
-
Prothena Corporation plc (NASDAQ:PRTA) Q4 2023 Earnings Call Transcript
16 Feb 2024 15:36 GMT
… you’re making point between bapineuzumab and lecanemab and I think … . As you say with the bapineuzumab work, I think there is …